Omeros (OMER) Cash & Equivalents (2010 - 2026)
Omeros (OMER) reported Cash & Equivalents of $1.9 million for Q1 2026, down 55.27% on a YoY basis from $4.3 million in Q1 2025, and down 80.27% sequentially from $9.7 million in Q4 2025.
Omeros (OMER) Cash & Equivalents (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Cash & Equivalents data on file, last reported at $1.9 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents fell 55.27% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (down 55.27% YoY), and the FY2025 full-year result was $9.7 million, up 184.12% from the prior year.
- Cash & Equivalents slipped to $1.9 million in Q1 2026, from $9.7 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $310.3 million in Q3 2023 to a low of $1.5 million in Q3 2024.
- A 5-year average of $48.6 million and a median of $9.0 million in 2022 frame the typical range for Cash & Equivalents.
- Peak annual rise in Cash & Equivalents reached 5960.53% in 2024, while the deepest fall reached 99.51% in 2024.
- Tracing OMER's Cash & Equivalents over 5 years: stood at $11.0 million in 2022, then tumbled by 35.46% to $7.1 million in 2023, then slumped by 52.15% to $3.4 million in 2024, then jumped by 184.12% to $9.7 million in 2025, then plunged by 80.27% to $1.9 million in 2026.
- Business Quant data shows OMER's Cash & Equivalents at $1.9 million in Q1 2026, $9.7 million in Q4 2025, and $36.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.91 Mn |
| Dec 31, 2025 | 9.66 Mn |
| Sep 30, 2025 | 36.10 Mn |
| Jun 30, 2025 | 28.70 Mn |
| Mar 31, 2025 | 4.26 Mn |
| Dec 31, 2024 | 3.40 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 230.30 Mn |
| Dec 31, 2023 | 7.11 Mn |
| Sep 30, 2023 | 310.30 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Mar 31, 2023 | 3.80 Mn |
| Dec 31, 2022 | 11.01 Mn |
| Sep 30, 2022 | 145.53 Mn |
| Jun 30, 2022 | 14.10 Mn |
| Mar 31, 2022 | 9.00 Mn |
| Dec 31, 2021 | 100.80 Mn |
| Sep 30, 2021 | 50.40 Mn |
| Jun 30, 2021 | 12.70 Mn |